Si-Bone (SIBN) Short term Debt (2019 - 2022)

Si-Bone's (SIBN) quarterly Short term Debt came in at $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.

Si-Bone (SIBN) Short term Debt (2019 - 2022) Analysis & Trends

Si-Bone's Short term Debt history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $1.5 million in Q3 2022; TTM through Sep 2022 was $1.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $4.4 million, changed N/A from the prior year.
  • Short term Debt fell to $1.5 million in Q3 2022 per SIBN's latest filing, from $8.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $8.7 million in Q1 2020 and bottomed at $1.5 million in Q3 2022.
  • The 3-year median for Short term Debt is $4.4 million (2019), against an average of $4.8 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.26 Bn 176.96 Bn 6.27 Bn
2 Stryker 128.82 Bn 125.94 Bn 3.81 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn
4 Boston Scientific 68.54 Bn 67.09 Bn 3.61 Bn
5 Edwards Lifesciences 47.53 Bn 43.86 Bn 1.29 Bn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn
7 Dexcom 28.43 Bn 27.31 Bn 750.30 Mn
8 Smith & Nephew 26.96 Bn 26.39 Bn -
9 Koninklijke Philips 25.53 Bn 22.41 Bn 2.07 Bn
10 Si-Bone 754.35 Mn 609.67 Mn 41.94 Mn

Historic Data

Download Data
DateValue
Sep 30, 2022 1.46 Mn
Mar 31, 2020 8.73 Mn
Dec 31, 2019 4.36 Mn